Add BrightSurf on Google Email

Many causes for learning lags in tumor disorder

New research sheds light on the complexities of learning problems in neurofibromatosis 1 patients. The study found that both increased RAS function and reduced dopamine levels contribute to cognitive dysfunction in individuals with NF1. Developing personalized therapies is now a priority.

SourceWashU Medicine·JournalAnnals of Neurology·DateDec 21, 2012

Stimulating brain cells with light

Scientists at Lund University are using optogenetics to investigate the behavior of transplanted brain cells in a model of Parkinson's disease. The study aims to determine whether light can be used to reinforce dopamine production and improve the effectiveness of nerve cell transplantation.

Challenging Parkinson's dogma

Researchers found dopamine neurons release GABA, a neurotransmitter that lowers neuronal activity, which could explain why restoring only dopamine leads to waning improvements in Parkinson's patients. This discovery highlights the complex interplay between dopamine and GABA in brain disorders like depression and addiction.

SourceHarvard Medical School·JournalNature·DateOct 24, 2012

Wayne State researcher's take on brain chemical analysis featured

A Wayne State University researcher has developed a new method for analyzing brain chemicals using carbon fiber microelectrodes. The technique, which meets four key criteria of size, speed, selectivity and sensitivity, enables researchers to measure serotonin levels in mice with antidepressants within five minutes.

Dopamine: A substance with many messages

Scientists from the Max Planck Institute identified four different types of dopamine-releasing nerve cells involved in forming positive and negative memories in fruit flies. These nerve cells use dopamine to communicate with other neurons, and their activation can signal aversive or rewarding stimuli.

SourceMax-Planck-Gesellschaft·JournalNature·DateJul 18, 2012

The role of dopamine in sleep regulation

Researchers discovered that dopamine inhibits melatonin production by forming 'heteromers' with norepinephrine receptors, regulating the body's circadian rhythm. This discovery could lead to new treatments for circadian rhythm disturbances and sleep disorders affecting 40% of the world's population.

SourcePLOS·JournalPLOS Biology·DateJun 19, 2012

Tracing the brain's connections

Scientists at Harvard University have created a comprehensive list of inputs that connect directly to dopamine neurons in the brain, revealing new connections and insights into Parkinson's disease and addiction. The study uses genetically-modified rabies virus to track neural pathways, providing quantitative data for future investigati...

SourceHarvard University·JournalNeuron·DateJun 6, 2012

Dopamine impacts your willingness to work

A Vanderbilt University study found that individual differences in dopamine levels in specific brain areas affect motivation and willingness to work for rewards. The research provides new insights into the role of dopamine in human behavior and may have implications for treating mental illnesses like depression and schizophrenia.

Appetite accomplice: Ghrelin receptor alters dopamine signaling

Research reveals a molecular partnership between ghrelin receptor and dopamine receptor in brain neurons that regulate appetite, shedding light on the underlying mechanisms of obesity and dopamine signaling disorders. The study suggests potential therapeutic targets with fewer side effects, offering new hope for treating these conditions.

SourceCell Press·JournalNeuron·DateJan 25, 2012

Reinforcing behavior in the brain

Researchers found that reward prediction error is the result of a complex interplay between dopamine and GABA neurons. The interaction helps calculate reward prediction error, shedding light on how behaviors can be reinforced through normal brain function or by damaging neuron interactions.

SourceHarvard University·JournalNature·DateJan 18, 2012

A new study suggests that a neurotransmitter might improve the treatment of cancer

Researchers found that dopamine injections improved blood flow to tumors, doubling the concentration of an anticancer drug and increasing its effectiveness. Dopamine also normalized the structure of abnormal tumor blood vessels, a condition typically associated with reduced chemotherapy and radiation therapy effectiveness.

SourceOhio State University Wexner Medical Center·JournalProceedings of the National Academy of Sciences·DateDec 5, 2011

1 neuron, 2 neurotransmitters and different effects on behavior

Researchers discovered that eliminating acetylcholine secretion boosted dopamine actions, potentially improving motor symptoms in Parkinson's disease. The study used genetically modified mice to investigate the role of neurotransmitters in the striatum, a region affected by the disease.

SourcePLOS·JournalPLOS Biology·DateNov 8, 2011

Brain scans reveal drugs' effects on attention

Researchers developed a brain scan method to quickly test whether drugs increase dopamine levels, alleviating attention deficits in mice with neurofibromatosis type 1. The technique may lead to matching specific treatments to patients with NF1 and attention deficit disorders.

SourceWashU Medicine·JournalExperimental Neurology·DateOct 13, 2011

In the brain, winning is everywhere

A study published in Neuron found that brain regions beyond the reward centers engage when playing games, suggesting a more widespread role for reward processing in the brain. The research used multi-voxel pattern analysis to identify patterns of brain activity associated with wins and losses.

SourceYale University·JournalNeuron·DateOct 5, 2011

JCI table of contents: June 23, 2011

Researchers discovered that ghrelin is required for prolonged psychosocial stress to promote preference for high-fat food in mice. A ketogenic diet also suppresses seizures by reducing adenosine levels, while HDL from patients with coronary artery disease has different effects on blood vessel lining cells compared to healthy individuals.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 23, 2011